BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7686993)

  • 1. Effects of age and dopamine agonists and antagonists on striatal dopamine release in the rat: an in vivo microdialysis study.
    Santiago M; Machado A; Cano J
    Mech Ageing Dev; 1993 Apr; 67(3):261-7. PubMed ID: 7686993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of intranigral application of MPP+ on nigral and bilateral striatal release of dopamine simultaneously recorded by microdialysis.
    Santiago M; Rollema H; de Vries JB; Westerink BH
    Brain Res; 1991 Jan; 538(2):226-30. PubMed ID: 1707325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective decrease in extracellular DOPAC concentrations in rat striatum following in vivo dialysis with low concentrations of MPP+.
    Caliguri EJ; Johannessen JN
    Brain Res; 1991 May; 548(1-2):94-9. PubMed ID: 1714336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT3 receptor agonist induced carrier-mediated release of dopamine in rat striatum in vivo.
    Santiago M; Machado A; Cano J
    Br J Pharmacol; 1995 Sep; 116(1):1545-50. PubMed ID: 8564217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex I inhibitor effect on the nigral and striatal release of dopamine in the presence and absence of nomifensine.
    Santiago M; Granero L; Machado A; Cano J
    Eur J Pharmacol; 1995 Jul; 280(3):251-6. PubMed ID: 8566093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of intracerebrally administered MPP+ (1-methyl-4-phenylpyridinium) in three species: microdialysis of dopamine and metabolites in mouse, rat and monkey striatum.
    Rollema H; Alexander GM; Grothusen JR; Matos FF; Castagnoli N
    Neurosci Lett; 1989 Dec; 106(3):275-81. PubMed ID: 2601882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microdialysis studies of basal levels and stimulus-evoked overflow of dopamine and metabolites in the striatum of young and aged Fischer 344 rats.
    Gerhardt GA; Maloney RE
    Brain Res; 1999 Jan; 816(1):68-77. PubMed ID: 9878690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo basal and amphetamine-induced striatal dopamine and metabolite levels are similar in the spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley male rats.
    Ferguson SA; Gough BJ; Cada AM
    Physiol Behav; 2003 Oct; 80(1):109-14. PubMed ID: 14568315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of adenylate cyclase in the modulation of the release of dopamine: a microdialysis study in the striatum of the rat.
    Santiago M; Westerink BH
    J Neurochem; 1990 Jul; 55(1):169-74. PubMed ID: 1693944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.
    Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
    J Neurochem; 1988 Feb; 50(2):346-55. PubMed ID: 2447237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine releasing response in rat striatum to single and repeated electroconvulsive shock treatment.
    Yoshida K; Higuchi H; Kamata M; Yoshimoto M; Shimizu T; Hishikawa Y
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 May; 21(4):707-15. PubMed ID: 9194151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats.
    Robertson GS; Damsma G; Fibiger HC
    J Neurosci; 1991 Jul; 11(7):2209-16. PubMed ID: 1712381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists.
    See RE; Sorg BA; Chapman MA; Kalivas PW
    Neuropharmacology; 1991 Dec; 30(12A):1269-74. PubMed ID: 1686300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction with pups enhances dopamine release in the ventral striatum of maternal rats: a microdialysis study.
    Hansen S; Bergvall AH; Nyiredi S
    Pharmacol Biochem Behav; 1993 Jul; 45(3):673-6. PubMed ID: 7687357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of naloxone on morphine-induced changes in striatal dopamine metabolism and glutamate, ascorbic acid and uric acid release in freely moving rats.
    Enrico P; Mura MA; Esposito G; Serra P; Migheli R; De Natale G; Desole MS; Miele M; Miele E
    Brain Res; 1998 Jun; 797(1):94-102. PubMed ID: 9630540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative microdialysis of dopamine in the striatum: effect of circadian variation.
    Smith AD; Olson RJ; Justice JB
    J Neurosci Methods; 1992 Aug; 44(1):33-41. PubMed ID: 1279321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of MPP+ on the release of serotonin and 5-hydroxyindoleacetic acid from rat striatum in vivo.
    Miyake H; Chiueh CC
    Eur J Pharmacol; 1989 Jul; 166(1):49-55. PubMed ID: 2478372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of extracellular dopamine and metabolite concentrations in rat striatum by low doses of acute cyamemazine.
    Peinado J; Hameg A; Garay RP; Bayle F; Nuss P; Dib M
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):134-9. PubMed ID: 12595954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effect of 17 beta-estradiol and lithium on ovariectomized rat brain biogenic amines metabolism.
    Morissette M; Paolo TD
    J Psychiatr Res; 1996; 30(2):95-107. PubMed ID: 8816304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responsiveness of striatal dopamine release in awake animals after chronic 1-methyl-4-phenylpyridinium ion-induced lesions of the substantia nigra.
    Santiago M; Westerink BH; Rollema H
    J Neurochem; 1991 Apr; 56(4):1336-42. PubMed ID: 2002346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.